Company Filing History:
4 out of 5,463 
1 out of 1,415 
Years Active: 2018-2022
Title: Maria Gaczynska: Innovator in Cancer Treatment
Introduction
Maria Gaczynska is a prominent inventor based in San Antonio, TX (US). She has made significant contributions to the field of cancer treatment through her innovative research and development of pharmaceutical compounds. With a total of 4 patents, her work focuses on modulating proteasome activity to combat uncontrolled cellular proliferation.
Latest Patents
Among her latest patents is a groundbreaking invention titled "Pipecolic esters for inhibition of the proteasome." This patent relates to chemical compounds that modulate proteasome activity, along with pharmaceutical compositions containing these compounds. The application of these compounds is aimed at treating disorders of uncontrolled cellular proliferation, such as cancer. Another notable patent is "Methods for the treatment of cancer metastasis," which provides methods for preventing or treating cancer metastasis by administering an allosteric ligand of proteasomes. This patent also includes methods for monitoring the efficacy of treatment with an allosteric ligand to reduce the metastatic potential of tumors.
Career Highlights
Maria has worked with esteemed institutions, including the University of Texas System and Michigan State University. Her research has been pivotal in advancing the understanding of cancer treatment methodologies and the development of new therapeutic strategies.
Collaborations
Throughout her career, Maria has collaborated with notable colleagues such as Pawel A Osmulski and Jetze J Tepe. These collaborations have further enriched her research and contributed to her innovative work in the field.
Conclusion
Maria Gaczynska's contributions to cancer treatment through her patents and research highlight her as a significant figure in the field of medical innovation. Her work continues to inspire advancements in the treatment of cancer and related disorders.